Tiba Biotech, LLC
Publicly observedCambridge, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Cambridge | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Tiba Biotech, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | XNL9ZSLHN795 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Aug 2026Publicly observed
NIH SBIR/STTR award: Lung-targeting delivery of small interfering RNA for pulmonary therapeutics
USD 396,805.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2025Publicly observed
NIH SBIR/STTR award: Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy
USD 399,300.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Feb 2022Publicly observed
NIH SBIR/STTR award: Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
USD 965,715.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.